Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response

Virology Journal

Volumn 8, Issue , 2011, Pages

  Liu, Wei ^a   Huber, Sally A ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

COXSACKIE VIRUS B; DENDRITIC CELL; EFFECTOR CELL; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; NATURAL KILLER CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIRUS MYOCARDITIS; ANIMAL; AUTOIMMUNITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; NATURAL KILLER T CELL;

COXSACKIEVIRUS; MUS;

ANIMALS; ANTIGENS, CD1D; AUTOIMMUNITY; HUMANS; IMMUNE TOLERANCE; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 78651577590     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-32     Document Type: Review

References (135)

1. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. WLW Liu C Gao NL Sun, J Autoimmun 2005 25 258 (Pubitemid 41642971)
2. Viral myocarditis. J Woodruff, Am J Pathol 1980 101 425 483 6254364
3. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death: a UK experience. ASM Fabre, Heart 2006 92 316 320 10.1136/hrt.2004.045518 15923280
4. Causes of sudden cardiac death in young Australians. ALN Doolan C Semsarian, Med J Aust 2004 180 110 112 14748671 (Pubitemid 38173103)
5. Sudden death in young adults: a 25-year review of autopsies in military recruits. RE Eckart SL Scoville CL Campbell EA Shry KC Stajduhar RN Potter LA Pearse R Virmani, Ann Intern Med 2004 141 829 834 15583223 (Pubitemid 39601175)
6. Sudden death in sports among young adults in Norway. EE Solberg F Gjertsen E Haugstad L Kolsrud, Eur J Cardiovasc Prev Rehabil 2010 17 337 341 20038839
7. Prevalence of myocarditis at autopsy in Turin, Italy. G Passarino P Burlo G Ciccone A Comino M Cravello P Iannicelli F Mollo, Arch Pathol Lab Med 1997 121 619 622 9199630 (Pubitemid 27259947)
8. The epidemiology of infectious myocarditis, lymphocytic and dilated cardiomyopathy. G Friman L Wesslen J Fohlman J Karjalainen C Rolf, Eur Heart J 1995 16 36 41 8682098 (Pubitemid 26082341)
9. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. NE Bowles J Ni DL Kearney M Pauschinger HP Schultheiss R McCarthy J Hare JT Bricker KR Bowles JA Towbin, J Am Coll Cardiol 2003 42 466 472 10.1016/S0735-1097(03)00648-X 12906974 (Pubitemid 36951713)
10. T lymphocytes kill T regulatory cells through CD1d. S Huber, Immunology 2010 131 202 209 10.1111/j.1365-2567.2010.03292.x 21050191
11. Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. J Woodruff J Woodruff, J Immunol 1974 113 1726 1734 4610045
12. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes. M Guthrie PA Lodge SA Huber, Cell Immunol 1984 88 558 567 10.1016/0008-8749(84)90188-6 6091924 (Pubitemid 15200464)
13. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackiebiral myocarditis. S Huber M Cunningham, J Immunol 1996 156 3528 3534 8617982 (Pubitemid 26123570)
14. Antigenic mimicry between self and coxsackievirus protein leads to both humoral and cellular autoimmunity to heart proteins. S Huber C Gauntt, Molecular Mimicry, Microbes, and Immunity Washington DC: ASM Press, Cunningham M, Fujinami R, 2000 57 68
15. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. KU Knowlton ES Jeon N Berkley R Wessely S Huber, J Virol 1996 70 7811 7818 8892902 (Pubitemid 26339087)
16. Role of CD1d in coxsackievirus B3-induced myocarditis. S Huber D Sartini M Exley, J Immunol 2003 170 3147 3153 12626572 (Pubitemid 36302191)
17. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis. S Huber WC Song D Sartini, Viral Immunol 2006 19 156 166 10.1089/vim.2006.19.156 16817758 (Pubitemid 44050314)
18. CD1d expression on hemopoietic cells promotes CD4+ Th1 response in coxsackievirus B3 induced myocarditis. SA Huber, Virology 2006 352 226 236 10.1016/j.virol.2006.04.014 16730774 (Pubitemid 44142687)
19. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. SA Huber AM Feldman D Sartini, Circ Res 2006 99 1109 1116 10.1161/01.RES.0000249405.13536.49 17038643 (Pubitemid 44729935)
20. The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity? RRHS Kulkarni S Sharif, J Leukoc Biol 2010 88 635 643 10.1189/jlb.0410191 20519638
21. Two classes of CD1 genes. F Calabi JM Jarvis L Martin C Milstein, Eur J Immunol 1989 19 285 292 10.1002/eji.1830190211 2467814 (Pubitemid 19098904)
22. Structure and function of the CD1 family of MHC-like cell surface proteins. RS Blumberg D Gerdes A Chott SA Porcelli SP Balk, Immunol Rev 1995 147 5 29 10.1111/j.1600-065X.1995.tb00085.x 8847079
23. Assistance of microbial glycolipid antigen processing by CD1e. H de la Salle S Mariotti C Angenieux M Gilleron LF Garcia-Alles D Malm T Berg S Paoletti B Maitre L Mourey, et al. Science 2005 310 1321 1324 10.1126/science.1115301 16311334 (Pubitemid 41698862)
24. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. M Exley J Garcia SB Wilson F Spada D Gerdes SM Tahir KT Patton RS Blumberg S Porcelli A Chott SP Balk, Immunology 2000 100 37 47 10.1046/j.1365-2567.2000.00001.x 10809957 (Pubitemid 30242880)
25. Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction. M Boes AJ Stoppelenburg FC Sille, Immunology 2009 127 163 170 10.1111/j.1365-2567.2009. 03078.x 19476512
26. Regulation of CD1 antigen-presenting complex stability. AN Odyniec DC Barral S Garg RV Tatituri GS Besra MB Brenner, J Biol Chem 2010 285 11937 11947 10.1074/jbc.M109.077933 20133943
27. TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1. RR Brutkiewicz JR Bennink JW Yewdell A Bendelac, J Exp Med 1995 182 1913 1919 10.1084/jem.182.6.1913 7500037 (Pubitemid 3007446)
28. Role of lipid trimming and CD1 groove size in cellular antigen presentation. TY Cheng M Relloso I Van Rhijn DC Young GS Besra V Briken DM Zajonc IA Wilson S Porcelli DB Moody, EMBO J 2006 25 2989 2999 10.1038/sj.emboj.7601185 16794581 (Pubitemid 44106752)
29. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. DM Zajonc MA Elsliger L Teyton IA Wilson, Nat Immunol 2003 4 808 815 10.1038/ni948 12833155 (Pubitemid 36986766)
30. The crystal structure of human CD1b with a bound bacterial glycolipid. T Batuwangala D Shepherd SD Gadola KJ Gibson NR Zaccai AR Fersht GS Besra V Cerundolo EY Jones, J Immunol 2004 172 2382 2388 14764708 (Pubitemid 38182387)
31. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. EM Beckman SA Porcelli CT Morita SM Behar ST Furlong MB Brenner, Nature 1994 372 691 694 10.1038/372691a0 7527500
32. CD1-restricted T cell recognition of microbial lipoglycan antigens. PA Sieling D Chatterjee SA Porcelli TI Prigozy RJ Mazzaccaro T Soriano BR Bloom MB Brenner M Kronenberg PJ Brennan, et al. Science 1995 269 227 230 10.1126/science.7542404 7542404
33. Polyisoprenyl glycolipids as targets of CD1-mediated T cell responses. DB Moody, Cell Mol Life Sci 2001 58 1461 1474 10.1007/PL00000789 11693527 (Pubitemid 32964416)
34. The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. A Shamshiev A Donda TI Prigozy L Mori V Chigorno CA Benedict L Kappos S Sonnino M Kronenberg G De Libero, Immunity 2000 13 255 264 10.1016/S1074-7613(00)00025-X 10981968
35. CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. EM Beckman A Melian SM Behar PA Sieling D Chatterjee ST Furlong R Matsumoto JP Rosat RL Modlin SA Porcelli, J Immunol 1996 157 2795 2803 8816382 (Pubitemid 126450032)
36. Recognition of bacterial glycosphingolipids by natural killer T cells. Y Kinjo D Wu G Kim GW Xing MA Poles DD Ho M Tsuji K Kawahara CH Wong M Kronenberg, Nature 2005 434 520 525 10.1038/nature03407 15791257 (Pubitemid 40477061)
37. Liver autoimmunity triggered by microbial activation of natural killer T cells. J Mattner PB Savage P Leung SS Oertelt V Wang O Trivedi ST Scanlon K Pendem L Teyton J Hart, et al. Cell Host Microbe 2008 3 304 315 10.1016/j.chom.2008.03.009 18474357 (Pubitemid 351637431)
38. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Y Kinjo E Tupin D Wu M Fujio R Garcia-Navarro MR Benhnia DM Zajonc G Ben-Menachem GD Ainge GF Painter, et al. Nat Immunol 2006 7 978 986 10.1038/ni1380 16921381 (Pubitemid 44263912)
39. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. J Mattner KL Debord N Ismail RD Goff C Cantu D Zhou P Saint-Mezard V Wang Y Gao N Yin, et al. Nature 2005 434 525 529 10.1038/nature03408 15791258 (Pubitemid 40477062)
40. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. T Kawano J Cui Y Koezuka I Toura Y Kaneko K Motoki H Ueno R Nakagawa H Sato E Kondo, et al. Science 1997 278 1626 1629 10.1126/science.278. 5343.1626 9374463 (Pubitemid 27516282)
41. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells. KC Roy I Maricic A Khurana TR Smith RC Halder V Kumar, J Immunol 2008 180 2942 2950 18292516
42. Synthesis and evaluation of human T cell stimulating activity of an alpha-sulfatide analogue. L Franchini P Matto F Ronchetti L Panza L Barbieri V Costantino A Mangoni M Cavallari L Mori G De Libero, Bioorg Med Chem 2007 15 5529 5536 10.1016/j.bmc.2007.05.044 17544671 (Pubitemid 46970820)
43. Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells. S Hegde L Fox X Wang JE Gumperz, Immunology 2010 130 471 483 10.1111/j.1365-2567.2010.03293.x 20465577
44. Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells. A Darmoise S Teneberg L Bouzonville RO Brady M Beck SH Kaufmann F Winau, Immunity 2010 33 216 228 10.1016/j.immuni. 2010.08.003 20727792
45. Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2. C Roura-Mir L Wang TY Cheng I Matsunaga CC Dascher SL Peng MJ Fenton C Kirschning DB Moody, J Immunol 2005 175 1758 1766 16034117 (Pubitemid 41023080)
46. The surprising diversity of lipid antigens for CD1-restricted T cells. DB Moody, Adv Immunol 2006 89 87 139 full-text 16682273
47. CD1 expression on antigen-presenting cells. SK Dougan A Kaser RS Blumberg, Curr Top Microbiol Immunol 2007 314 113 141 full-text 17593659
48. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. F Sallusto A Lanzavecchia, J Exp Med 1994 179 1109 1118 10.1084/jem.179.4.1109 8145033
49. Role of CD1d-restricted NKT cells in microbial immunity. M Skold SM Behar, Infect Immun 2003 71 5447 5455 10.1128/IAI.71.10.5447-5455.2003 14500461 (Pubitemid 37205594)
50. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. E Durante-Mangoni R Wang A Shaulov Q He I Nasser N Afdhal MJ Koziel MA Exley, J Immunol 2004 173 2159 2166 15265953 (Pubitemid 38971655)
51. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation. M Skold X Xiong PA Illarionov GS Besra SM Behar, J Immunol 2005 175 3584 3593 16148102 (Pubitemid 41292017)
52. IFN-beta-mediated up-regulation of CD1d in bacteria-infected APCs. G Raghuraman Y Geng CR Wang, J Immunol 2006 177 7841 7848 17114455 (Pubitemid 44846300)
53. Roles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis. SA Huber D Sartini, J Virol 2005 79 2659 2665 10.1128/JVI.79.5.2659-2665.2005 15708985 (Pubitemid 40270544)
54. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). JM Bergelson JG Mohanty RL Crowell NF St John DM Lublin RW Finberg, J Virol 1995 69 1903 1906 7531780
55. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form. WC Song C Deng K Raszmann R Moore R Newbold JA McLachlan M Negishi, J Immunol 1996 157 4166 4172 8892654 (Pubitemid 126449331)
56. Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. T Miwa MA Maldonado L Zhou X Sun HY Luo D Cai VP Werth MP Madaio RA Eisenberg WC Song, Am J Pathol 2002 161 1077 1086 10.1016/S0002-9440(10)64268-X 12213736 (Pubitemid 34988395)
57. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity. T Miwa X Sun R Ohta N Okada CL Harris BP Morgan WC Song, Immunology 2001 104 207 214 10.1046/j.1365-2567.2001.01280.x 11683961 (Pubitemid 32989521)
58. Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells. I Peiffer AL Servin MF Bernet-Camard, Infect Immun 1998 66 4036 4042 9712744 (Pubitemid 28402668)
59. Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibility. SA Huber M Rincon, Virology 2008 381 155 160 10.1016/j.virol.2008.08.020 18829062
60. Inhibition of CD1 antigen presentation by human cytomegalovirus. MJ Raftery M Hitzler F Winau T Giese B Plachter SH Kaufmann G Schonrich, J Virol 2008 82 4308 4319 10.1128/JVI.01447-07 18287231 (Pubitemid 351563668)
61. Inhibition of groups 1 and 2 CD1 molecules on human dendritic cells by Leishmania species. MJ Donovan A Jayakumar MA McDowell, Parasite Immunol 2007 29 515 524 10.1111/j.1365-3024.2007.00970.x 17883454 (Pubitemid 47460179)
62. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. MJ Raftery F Winau SH Kaufmann UE Schaible G Schonrich, J Immunol 2006 177 6207 6214 17056550 (Pubitemid 44628839)
63. TLR7/8 agonists impair monocyte-derived dendritic cell differentiation and maturation. E Assier V Marin-Esteban A Haziot E Maggi D Charron N Mooney, J Leukoc Biol 2007 81 221 228 10.1189/jlb.0705385 17023556 (Pubitemid 46021272)
64. NKT Cells Are Critical to Initiate an Inflammatory Response after Pseudomonas aeruginosa Ocular Infection in Susceptible Mice. LD Hazlett Q Li J Liu S McClellan W Du RP Barrett, J Immunol 2007 179 1138 1146 17617607
65. Activation of Valpha14(+) natural killer T cells by alpha- galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. K Kawakami Y Kinjo S Yara Y Koguchi K Uezu T Nakayama M Taniguchi A Saito, Infect Immun 2001 69 213 220 10.1128/IAI.69.1.213-220.2001 11119508 (Pubitemid 32038317)
66. Importance of NKT cells in resistance to herpes simplex virus, fate of virus-infected neurons, and level of latency in mice. B Grubor-Bauk JL Arthur G Mayrhofer, J Virol 2008 82 11073 11083 10.1128/JVI.00205-08 18614643
67. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo. PO Ilyinskii R Wang SP Balk MA Exley, J Virol 2006 80 7146 7158 10.1128/JVI.02745-05 16809320 (Pubitemid 44025211)
68. Innate immune response to encephalomyocarditis virus infection mediated by CD1d. MA Exley NJ Bigley O Cheng A Shaulov SM Tahir QL Carter J Garcia C Wang K Patten HF Stills, et al. Immunology 2003 110 519 526 10.1111/j.1365-2567. 2003.01779.x 14632651 (Pubitemid 37521883)
69. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus. TR Johnson S Hong L Van Kaer Y Koezuka BS Graham, J Virol 2002 76 4294 4303 10.1128/JVI.76.9.4294- 4303.2002 11932395 (Pubitemid 34309565)
70. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. JAGA Harker JL Wahlsten DC Lee LG Thorne D Sawant JS Tregoning RR Caspi A Bukreyev PL Collins PJ Openshaw, J Virol 2010 84 4073 4082 10.1128/JVI.02014-09 20130064
71. The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. M Taniguchi T Tashiro N Dashtsoodol N Hongo H Watarai, Int Immunol 2010 22 1 6 10.1093/intimm/dxp104 19858073
72. Immune regulation by invariant NKT cells in autoimmunity. F Ronchi M Falcone, Front Biosci 2008 13 4827 4837 10.2741/3042 18508548 (Pubitemid 351599638)
73. Toward an understanding of NKT cell biology: progress and paradoxes. M Kronenberg, Annu Rev Immunol 2005 3 877 900 10.1146/annurev.immunol.23.021704. 115742 (Pubitemid 40563188)
74. The role of NKT cells in tumor immunity. M Terabe JA Berzofsky, Adv Cancer Res 2008 101 277 348 10.1016/S0065-230X(08)00408-9 19055947
75. The biology of NKT cells. A Bendelac PB Savage L Teyton, Annu Rev Immunol 2007 25 297 336 10.1146/annurev.immunol.25.022106.141711 17150027 (Pubitemid 46697911)
76. Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis. CM Olson Jr TC Bates H Izadi JD Radolf SA Huber JE Boyson J Anguita, J Immunol 2009 182 3728 3734 10.4049/jimmunol.0804111 19265151
77. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. MLKA Michel C Paget M Fujio F Trottein PB Savage CH Wong E Schneider M Dy MC Leite-de-Moraes, J Exp Med 2007 204 995 1001 10.1084/jem.20061551 17470641 (Pubitemid 46798144)
78. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. DB Stetson M Mohrs RL Reinhardt JL Baron ZE Wang L Gapin M Kronenberg RM Locksley, J Exp Med 2003 198 1069 1076 10.1084/jem.20030630 14530376 (Pubitemid 37248622)
79. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. M Brigl L Bry SC Kent JE Gumperz MB Brenner, Nat Immunol 2003 4 1230 1237 10.1038/ni1002 14578883 (Pubitemid 37540692)
80. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. S Seki Y Habu T Kawamura K Takeda H Dobashi T Ohkawa H Hiraide, Immunol Rev 2000 174 35 46 10.1034/j.1600-0528.2002.017404.x 10807505 (Pubitemid 30201377)
81. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. C Carnaud D Lee O Donnars SH Park A Beavis Y Koezuka A Bendelac, J Immunol 1999 163 4647 4650 10528160 (Pubitemid 29501223)
82. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation. G Gigli S Caielli D Cutuli M Falcone, Immunology 2007 122 409 417 10.1111/j.1365-2567.2007.02655.x 17617156 (Pubitemid 47556478)
83. Dendritic cell differentiation state and their interaction with NKT cells determine Th1/Th2 differentiation in the murine model of Leishmania major infection. C Wiethe A Debus M Mohrs A Steinkasserer M Lutz A Gessner, J Immunol 2008 180 4371 4381 18354157
84. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. P Arrenberg R Halder V Kumar, J Cell Physiol 2009 218 246 250 10.1002/jcp.21597 18814145
85. Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells. N Duarte M Stenstrom S Campino ML Bergman M Lundholm D Holmberg SL Cardell, J Immunol 2004 173 3112 3118 15322171 (Pubitemid 39142017)
86. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. A Jahng I Maricic C Aguilera S Cardell RC Halder V Kumar, J Exp Med 2004 199 947 957 10.1084/jem.20031389 15051763 (Pubitemid 38481086)
87. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. RC Halder C Aguilera I Maricic V Kumar, J Clin Invest 2007 117 2302 2312 10.1172/JCI31602 17641782 (Pubitemid 47219575)
88. Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. E Ambrosino M Terabe RC Halder J Peng S Takaku S Miyake T Yamamura V Kumar JA Berzofsky, J Immunol 2007 179 5126 5136 17911598
89. Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. FM Spada EP Grant PJ Peters M Sugita A Melian DS Leslie HK Lee E van Donselaar DA Hanson AM Krensky, et al. J Exp Med 2000 191 937 948 10.1084/jem.191.6.937 10727456
90. Human gammadelta T cell recognition of lipid A is predominately presented by CD1b or CD1c on dendritic cells. Y Cui L Kang L Cui W He, Biol Direct 2009 4 47 10.1186/1745-6150-4-47 19948070
91. Recognition of MHC TL gene products by gamma delta T cells. L Van Kaer M Wu Y Ichikawa K Ito M Bonneville S Ostrand-Rosenberg DB Murphy S Tonegawa, Immunol Rev 1991 120 89 115 10.1111/j.1600-065X.1991.tb00589.x 1830863
92. Antigen recognition by gammadelta T cells. YH Chien Y Konigshofer, Immunol Rev 2007 215 46 58 10.1111/j.1600-065X.2006.00470.x 17291278
93. Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d. SA Huber, Med Microbiol Immunol 2005 194 121 127 10.1007/s00430-004-0221-6 15107990 (Pubitemid 41202528)
94. Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma-delta+ T cell receptor. S Huber A Mortensen G Moulton, J Virol 1996 70 3039 3045 8627781
95. Cytokine Production by Vgamma+ T Cell Subsets is an Important Factor Determining CD4+ Th Cell Phenotype and Susceptibility of BALB/c mice to Coxsackievirus B3-Induced Myocarditis. S Huber D Graveline W Born R O'Brien, J Virol 2001 75 5860 5868 10.1128/JVI.75.13.5860-5869.2001 11390587
96. CD1-mediated gamma/delta T cell maturation of dendritic cells. DS Leslie MS Vincent FM Spada H Das M Sugita CT Morita MB Brenner, J Exp Med 2002 196 1575 1584 10.1084/jem.20021515 12486100 (Pubitemid 36026469)
97. Lyme arthritis synovial gammadelta T cells instruct dendritic cells via fas ligand. C Collins J Wolfe K Roessner C Shi LH Sigal RC Budd, J Immunol 2005 175 5656 5665 16237055 (Pubitemid 41508047)
98. T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis. S Huber A Moraska M Choate, J Virol 1992 66 6541 6546 1328680
99. Depletion of gammadelta+ T cells increases CD4+ FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis. SA Huber, Immunology 2009 127 567 576 10.1111/j.1365-2567.2008.03034.x 19604307
100. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. SA Huber D Sartini M Exley, J Virol 2002 76 10785 10790 10.1128/JVI.76.21.10785-10790.2002 12368321 (Pubitemid 35176195)
101. Gamma-delta T-cell-mediated dilated cardiomyopathy. N Takeda Y Seko N Oriuchi R Nagai, Int J Cardiol 2008 125 130 132 10.1016/j.ijcard.2007.01.068 17433841 (Pubitemid 351305412)
102. Takayasu myocarditis mediated by cytotoxic T lymphocytes. N Takeda T Takahashi Y Seko K Maemura H Nakasone K Sakamoto Y Hirata R Nagai, Intern Med 2005 44 256 260 10.2169/internalmedicine.44.256 15805718 (Pubitemid 40575909)
103. Active fulminant myocarditis characterized by T-lymphocytes expressing the gamma-delta T-cell receptor: a new disease entity? M Eck A Greiner R Kandolf B Schmausser A Marx HK Muller-Hermelink, Am J Surg Pathol 1997 21 1109 1112 10.1097/00000478-199709000-00017 9298889 (Pubitemid 27407297)
104. Coxsackievirus B3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. S Huber P Lodge, Am J Path 1984 116 21 26 6331168
105. Immunopathogenic mechanisms in experimental picornavirus-induced autoimmunity. S Huber A Weller M Herzum P Lodge M Estrin K Simpson M Guthrie, Immunopathol Res 1988 7 279 291 10.1159/000157123
106. The role of T lymphocytes in the pathogenesis of coxsackievirus B3 myocarditis. S Huber P Lodge M Herzum M Estrin J Olszewski, Cardiomyopathy Update 1: Pathogenesis of Myocarditis and Cardiomyopathy Tokyo: University of Tokyo Press, Kawai C, Abelmann W, Matsumori A, 1987 9 21
107. Regulatory T cells in human autoimmune diseases. TR Torgerson, Springer Semin Immunopathol 2006 28 63 76 10.1007/s00281-006-0041-4 16902772 (Pubitemid 44267960)
108. Regulatory T cells and immune tolerance. S Sakaguchi T Yamaguchi T Nomura M Ono, Cell 2008 133 775 787 10.1016/j.cell.2008.05.009 18510923 (Pubitemid 351707693)
109. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. S Sakaguchi, Nat Immunol 2005 6 345 352 10.1038/ni1178 15785760 (Pubitemid 41716771)
110. Tolerance, not immunity, crucially depends on IL-2. TR Malek AL Bayer, Nat Rev Immunol 2004 4 665 674 10.1038/nri1435 15343366 (Pubitemid 39223073)
111. Regulatory T cells in many flavors control asthma. A Ray A Khare N Krishnamoorthy Z Qi P Ray, Mucosal Immunol 2010 3 216 229 10.1038/mi.2010.4 20164832
112. T regulatory cells and their counterparts: masters of immune regulation. C Ozdemir M Akdis CA Akdis, Clin Exp Allergy 2009 39 626 639 10.1111/j.1365-2222.2009.03242.x 19422105
113. Treatment and prevention of experimental autoimmune myocarditis with CD28 superagonists. SLJ Wang M Wang J Zhang Z Wang, Cardiology 2010 115 107 113 10.1159/000256660 19907173
114. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. S Frisancho-Kiss JF Nyland SE Davis MA Barrett SJ Gatewood DB Njoku D Cihakova EK Silbergeld NR Rose D Fairweather, J Immunol 2006 176 6411 6415 16709797 (Pubitemid 43787822)
115. Selection of an attenuated coxsackievirus B3 variant using a monoclonal antibody reactive to myocyte antigen. N Van Houten P Bouchard A Moraska S Huber, J Virol 1991 65 1286 1290 1847455
116. Oral nickel tolerance: Fas ligand-expressing invariant NK T cells promote tolerance induction by eliciting apoptotic death of antigen-carrying, effete B cells. M Nowak F Kopp K Roelofs-Haarhuis X Wu E Gleichmann, J Immunol 2006 176 4581 4589 16585548
117. Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. K Roelofs-Haarhuis X Wu E Gleichmann, J Immunol 2004 173 1043 1050 15240692 (Pubitemid 38924278)
118. Infectious nickel tolerance: a reciprocal interplay of tolerogenic APCs and T suppressor cells that is driven by immunization. K Roelofs-Haarhuis X Wu M Nowak M Fang S Artik E Gleichmann, J Immunol 2003 171 2863 2872 12960308 (Pubitemid 37093506)
119. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. KH Sonoda M Exley S Snapper SP Balk J Stein-Streilein, J Exp Med 1999 190 1215 1226 10.1084/jem.190.9.1215 10544194
120. CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. A La Cava L Van Kaer S Fu Dong, Trends Immunol 2006 27 322 327 10.1016/j.it.2006.05. 003 16735139
121. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. D Ly QS Mi S Hussain TL Delovitch, J Immunol 2006 177 3695 3704 16951329 (Pubitemid 44359901)
122. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. SL Cardell, Clin Exp Immunol 2006 143 194 202 10.1111/j.1365-2249.2005.02942.x 16412042
123. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. S Hong MT Wilson I Serizawa L Wu N Singh OV Naidenko T Miura T Haba DC Scherer J Wei, et al. Nat Med 2001 7 1052 1056 10.1038/nm0901-1052 11533710 (Pubitemid 32937387)
124. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. KH Sonoda DE Faunce M Taniguchi M Exley S Balk J Stein-Streilein, J Immunol 2001 166 42 50 11123275 (Pubitemid 32038415)
125. Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages. J Stein-Streilein KH Sonoda D Faunce J Zhang-Hoover, J Leukoc Biol 2000 67 488 494 10770280
126. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. P McGuirk KH Mills, Trends Immunol 2002 23 450 455 10.1016/S1471-4906(02)02288-3 12200067 (Pubitemid 35015189)
127. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. A Kumanogoh X Wang I Lee C Watanabe M Kamanaka W Shi K Yoshida T Sato S Habu M Itoh, et al. J Immunol 2001 166 353 360 11123312 (Pubitemid 32038452)
128. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. B Salomon DJ Lenschow L Rhee N Ashourian B Singh A Sharpe JA Bluestone, Immunity 2000 12 431 440 10.1016/S1074-7613(00)80195-8 10795741
129. The role of innate immunity in autoimmunity. JF Bach A Bendelac MB Brenner H Cantor G De Libero M Kronenberg LL Lanier DH Raulet MJ Shlomchik MG von Herrath, J Exp Med 2004 200 1527 1531 10.1084/jem.20042110 15611284 (Pubitemid 40094176)
130. Natural killer cells modulate overt autoimmunity to homeostasis in nonobese diabetic mice after anti-CD3 F(ab')2 antibody treatment through secreting transforming growth factor-beta. G Chen G Han J Wang R Wang R Xu B Shen J Qian Y Li, Am J Pathol 2009 175 1086 1094 10.2353/ajpath.2009.080488 19644014
131. gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. F Petermann V Rothhammer MC Claussen JD Haas LR Blanco S Heink I Prinz B Hemmer VK Kuchroo M Oukka T Korn, Immunity 2010 33 351 363 10.1016/j.immuni.2010.08.013 20832339
132. Vgamma1+ gammadelta T cells reduce IL-10-producing CD4+CD25+ T cells in the lung of ovalbumin-sensitized and challenged mice. YS Hahn XY Ji SI Woo YK Choi MS Song KS Shin N Jin RL O'Brien WK Born, Immunol Lett 2008 121 87 92 10.1016/j.imlet.2008.09.001 18840468
133. Phosphoantigen-activated V gamma 2V delta 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection. G Gong L Shao Y Wang CY Chen D Huang S Yao X Zhan H Sicard R Wang ZW Chen, Blood 2009 113 837 845 10.1182/blood-2008-06-162792 18981295
134. Mouse CD1-specific NK1 T cells: development, specificity, and function. A Bendelac MN Rivera SH Park JH Roark, Annu Rev Immunol 1997 15 535 562 10.1146/annurev.immunol.15.1.535 9143699 (Pubitemid 27169416)
135. Gammadelta T cells: functional plasticity and heterogeneity. SR Carding PJ Egan, Nat Rev Immunol 2002 2 336 345 10.1038/nri797 12033739 (Pubitemid 37328756)